1300 related articles for article (PubMed ID: 32588943)
1. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).
Zhou Y; Chi J; Lv W; Wang Y
Diabetes Metab Res Rev; 2021 Feb; 37(2):e3377. PubMed ID: 32588943
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
Landstra CP; de Koning EJP
Front Endocrinol (Lausanne); 2021; 12():649525. PubMed ID: 34220706
[TBL] [Abstract][Full Text] [Related]
3. Diabetes, obesity and COVID-19: A complex interplay.
Vas P; Hopkins D; Feher M; Rubino F; B Whyte M
Diabetes Obes Metab; 2020 Oct; 22(10):1892-1896. PubMed ID: 32627299
[TBL] [Abstract][Full Text] [Related]
4. The Centrality of Obesity in the Course of Severe COVID-19.
Liu D; Zhang T; Wang Y; Xia L
Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
[TBL] [Abstract][Full Text] [Related]
5. Impact of obesity on COVID-19 patients.
Yu W; Rohli KE; Yang S; Jia P
J Diabetes Complications; 2021 Mar; 35(3):107817. PubMed ID: 33358523
[TBL] [Abstract][Full Text] [Related]
6. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
Pugliese G; Vitale M; Resi V; Orsi E
Acta Diabetol; 2020 Nov; 57(11):1275-1285. PubMed ID: 32865671
[TBL] [Abstract][Full Text] [Related]
7. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.
Shah H; Khan MSH; Dhurandhar NV; Hegde V
Acta Diabetol; 2021 Jul; 58(7):831-843. PubMed ID: 33587177
[TBL] [Abstract][Full Text] [Related]
8. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection.
Wu J; Zhang J; Sun X; Wang L; Xu Y; Zhang Y; Liu X; Dong C
Diabetes Obes Metab; 2020 Oct; 22(10):1907-1914. PubMed ID: 32496012
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme 2 as a versatile player in the management of coronavirus disease 2019.
Amano T
J Diabetes Investig; 2020 Sep; 11(5):1120-1122. PubMed ID: 32657484
[No Abstract] [Full Text] [Related]
10. Preadmission predictors of severe COVID-19 in patients with diabetes mellitus.
Shukla AP; Tchang BG; Lam T; Steller I; Touhamy S; Askin G; Mendelsohn Curanaj FA; Seley JJ; Lorber D; Safford MM; Aronne LJ; Alonso LC
J Diabetes Complications; 2021 Aug; 35(8):107967. PubMed ID: 34099384
[TBL] [Abstract][Full Text] [Related]
11. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis.
Schlesinger S; Neuenschwander M; Lang A; Pafili K; Kuss O; Herder C; Roden M
Diabetologia; 2021 Jul; 64(7):1480-1491. PubMed ID: 33907860
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and covid-19: more than the sum of two morbidities.
Pititto BA; Ferreira SRG
Rev Saude Publica; 2020; 54():54. PubMed ID: 32491053
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.
Sharif N; Ahmed SN; Opu RR; Tani MR; Dewan D; Daullah MU; Shanto RI; Parvez AK; Talukder AA; Dey SK
Diabetes Metab Syndr; 2021; 15(3):1009-1016. PubMed ID: 33993046
[TBL] [Abstract][Full Text] [Related]
14. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in diabetic patients: Related risks and specifics of management.
Orioli L; Hermans MP; Thissen JP; Maiter D; Vandeleene B; Yombi JC
Ann Endocrinol (Paris); 2020 Jun; 81(2-3):101-109. PubMed ID: 32413342
[TBL] [Abstract][Full Text] [Related]
17. Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture.
Luzi L; Carruba M; Crialesi R; Da Empoli S; Dagani R; Lovati E; Nicolucci A; Berra CC; Cipponeri E; Vaccaro K; Lenzi A
Acta Diabetol; 2021 Jul; 58(7):919-927. PubMed ID: 33740123
[TBL] [Abstract][Full Text] [Related]
18. Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity.
Kim NH; Kim KJ; Choi J; Kim SG
Metabolism; 2022 Mar; 128():154894. PubMed ID: 34600905
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
[TBL] [Abstract][Full Text] [Related]
20. Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis.
Du Y; Lv Y; Zha W; Zhou N; Hong X
Metabolism; 2021 Apr; 117():154373. PubMed ID: 32949592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
